http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 16:36:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30/26931678.html si-local-file:///var/storage/secattach/20260814/26931678.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30/26931678.html Fri, 14 Aug 2026 16:36:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30/26931678.html si-local-file:///var/storage/secattach/20260814/26931678.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30/26931678.html Fri, 14 Aug 2026 16:36:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Aug+06++Filed+by%3A+Weis+Holger/26905908.html si-local-file:///var/storage/secattach/20260811/26905908.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Aug+06++Filed+by%3A+Weis+Holger/26905908.html Tue, 11 Aug 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Aug+06++Filed+by%3A+Weis+Holger/26905908.html si-local-file:///var/storage/secattach/20260811/26905908.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Aug+06++Filed+by%3A+Weis+Holger/26905908.html Tue, 11 Aug 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Jerman+Michael+Allen/26819780.html si-local-file:///var/storage/secattach/20260727/26819780.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Jerman+Michael+Allen/26819780.html Mon, 27 Jul 2026 16:16:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Jerman+Michael+Allen/26819780.html si-local-file:///var/storage/secattach/20260727/26819780.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Jerman+Michael+Allen/26819780.html Mon, 27 Jul 2026 16:16:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Postma+Robert+W/26819743.html si-local-file:///var/storage/secattach/20260727/26819743.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Postma+Robert+W/26819743.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Postma+Robert+W/26819743.html si-local-file:///var/storage/secattach/20260727/26819743.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Postma+Robert+W/26819743.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Vieser+Jaime/26819747.html si-local-file:///var/storage/secattach/20260727/26819747.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Vieser+Jaime/26819747.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Vieser+Jaime/26819747.html si-local-file:///var/storage/secattach/20260727/26819747.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Vieser+Jaime/26819747.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Weis+Holger/26819752.html si-local-file:///var/storage/secattach/20260727/26819752.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Weis+Holger/26819752.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Weis+Holger/26819752.html si-local-file:///var/storage/secattach/20260727/26819752.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jul+23++Filed+by%3A+Weis+Holger/26819752.html Mon, 27 Jul 2026 16:15:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Alaunos+Therapeutics%2C++++++++++++++++/26732147.html si-local-file:///var/storage/secattach/20260706/26732147.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Alaunos+Therapeutics%2C++++++++++++++++/26732147.html Mon, 06 Jul 2026 06:03:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Alaunos+Therapeutics%2C++++++++++++++++/26732147.html si-local-file:///var/storage/secattach/20260706/26732147.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Alaunos+Therapeutics%2C++++++++++++++++/26732147.html Mon, 06 Jul 2026 06:03:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30++Filed+by%3A+Weis+Holger/26729694.html si-local-file:///var/storage/secattach/20260702/26729694.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30++Filed+by%3A+Weis+Holger/26729694.html Thu, 02 Jul 2026 17:34:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30++Filed+by%3A+Weis+Holger/26729694.html si-local-file:///var/storage/secattach/20260702/26729694.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+30++Filed+by%3A+Weis+Holger/26729694.html Thu, 02 Jul 2026 17:34:00 -0400 O.01405601 TCRT http://www.streetinsider.com/Corporate+News/Alaunos+shares+preclinical+liver+data+for+metabolic+drug+ALN1003/26702707.html <p>Alaunos Therapeutics (Nasdaq: TCRT) released a new statistical analysis from a preclinical mouse study of its investigational oral small-molecule candidate ALN1003, showing lower liver weight in treated animals after adjustment for body fat percentage.</p><p>The analysis, drawn from a previously reported non-Good Laboratory Practice diet-induced obesity mouse study conducted over 48 days, found a statistically significant difference in liver weight between ALN1003-treated animals and controls after adjusting for body fat percentage, with a p-value of 0.000005 in a standard ANCOVA analysis. A sensitivity analysis using heteroscedasticity-robust HC3 standard errors produced a p-value of 0.000015.</p><p>According to the company, the finding indicates the http://www.streetinsider.com/Corporate+News/Alaunos+shares+preclinical+liver+data+for+metabolic+drug+ALN1003/26702707.html Mon, 29 Jun 2026 08:35:26 -0400 TCRT http://www.streetinsider.com/FDA/Alaunos+shares+preclinical+liver+data+for+metabolic+drug+ALN1003/26702707.html <p>Alaunos Therapeutics (Nasdaq: TCRT) released a new statistical analysis from a preclinical mouse study of its investigational oral small-molecule candidate ALN1003, showing lower liver weight in treated animals after adjustment for body fat percentage.</p><p>The analysis, drawn from a previously reported non-Good Laboratory Practice diet-induced obesity mouse study conducted over 48 days, found a statistically significant difference in liver weight between ALN1003-treated animals and controls after adjusting for body fat percentage, with a p-value of 0.000005 in a standard ANCOVA analysis. A sensitivity analysis using heteroscedasticity-robust HC3 standard errors produced a p-value of 0.000015.</p><p>According to the company, the finding indicates the http://www.streetinsider.com/FDA/Alaunos+shares+preclinical+liver+data+for+metabolic+drug+ALN1003/26702707.html Mon, 29 Jun 2026 08:35:26 -0400 TCRT http://www.streetinsider.com/Press+Releases/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html <ul type="disc"><li style="margin-bottom:8pt; text-align:justify;"><em>This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this model</em></li><li style="margin-bottom:8pt; text-align:justify;"><em>Liver-weight findings are directionally consistent with previously disclosed data on lower liver injury enzymes, lower NAFLD Activity Scores (NAS), lower HOMA-IR, an insulin-resistance-related biomarker</em>, and<em> favorable adipose endocrine signaling<br/><br/></em></li></ul> <p align="justify">FORT LAUDERDALE, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT), an early-stage biotechnology company developing novel therapeutics, today announced a new preclinical statistical analysis of liver weight adjusted for body fat http://www.streetinsider.com/Press+Releases/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html Mon, 29 Jun 2026 08:35:00 -0400 O.01405601 TCRT http://www.streetinsider.com/Press+Releases/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html <ul type="disc"><li style="margin-bottom:8pt; text-align:justify;"><em>This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this model</em></li><li style="margin-bottom:8pt; text-align:justify;"><em>Liver-weight findings are directionally consistent with previously disclosed data on lower liver injury enzymes, lower NAFLD Activity Scores (NAS), lower HOMA-IR, an insulin-resistance-related biomarker</em>, and<em> favorable adipose endocrine signaling<br/><br/></em></li></ul> <p align="justify">FORT LAUDERDALE, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT), an early-stage biotechnology company developing novel therapeutics, today announced a new preclinical statistical analysis of liver weight adjusted for body fat http://www.streetinsider.com/Press+Releases/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html Mon, 29 Jun 2026 08:35:00 -0400 O.01405601 TCRT http://www.streetinsider.com/Globe+Newswire/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html <ul type="disc"><li style="margin-bottom:8pt; text-align:justify;"><em>This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this model</em></li><li style="margin-bottom:8pt; text-align:justify;"><em>Liver-weight findings are directionally consistent with previously disclosed data on lower liver injury enzymes, lower NAFLD Activity Scores (NAS), lower HOMA-IR, an insulin-resistance-related biomarker</em>, and<em> favorable adipose endocrine signaling<br/><br/></em></li></ul> <p align="justify">FORT LAUDERDALE, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT), an early-stage biotechnology company developing novel therapeutics, today announced a new preclinical statistical analysis of liver weight adjusted for body fat http://www.streetinsider.com/Globe+Newswire/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html Mon, 29 Jun 2026 08:35:00 -0400 O.01405601 TCRT http://www.streetinsider.com/Globe+Newswire/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html <ul type="disc"><li style="margin-bottom:8pt; text-align:justify;"><em>This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this model</em></li><li style="margin-bottom:8pt; text-align:justify;"><em>Liver-weight findings are directionally consistent with previously disclosed data on lower liver injury enzymes, lower NAFLD Activity Scores (NAS), lower HOMA-IR, an insulin-resistance-related biomarker</em>, and<em> favorable adipose endocrine signaling<br/><br/></em></li></ul> <p align="justify">FORT LAUDERDALE, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT), an early-stage biotechnology company developing novel therapeutics, today announced a new preclinical statistical analysis of liver weight adjusted for body fat http://www.streetinsider.com/Globe+Newswire/Alaunos+Reports+New+Preclinical+ALN1003+Data+Showing+Lower+Liver+Weight+After+Adjustment+for+Body+Fat+Percentage+in+48-Day+DIO+Mouse+Study/26702703.html Mon, 29 Jun 2026 08:35:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+29/26702633.html si-local-file:///var/storage/secattach/20260629/26702633.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+29/26702633.html Mon, 29 Jun 2026 08:31:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+29/26702633.html si-local-file:///var/storage/secattach/20260629/26702633.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+29/26702633.html Mon, 29 Jun 2026 08:31:00 -0400 O.01405601 TCRT http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+17++Filed+by%3A+Weis+Holger/26660689.html si-local-file:///var/storage/secattach/20260617/26660689.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Alaunos+Therapeutics%2C+++++For%3A+Jun+17++Filed+by%3A+Weis+Holger/26660689.html Wed, 17 Jun 2026 16:48:00 -0400 O.01405601 TCRT